AzTrials
AzTrials

Social Anxiety DisorderNCT03709615

Therapeutic Processes in iCBT for SAD

A study testing Internet delivered CBT for social anxiety disorder in people with Social Anxiety Disorder and Social Phobia, run by University of Haifa at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study examines therapeutic processes during internet-based cognitive-behavioral therapy for social anxiety disorder. Participants will be randomized to either treatment or wait-list conditions. Participants in the wait-list condition will receive active treatment following the wait-list period. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Social Anxiety Disorder, Social Phobia
What is being tested?
Internet delivered CBT for social anxiety disorder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteIsrael
Study dates
20 Dec 2017to 20 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Meeting DSM-5 criteria for social anxiety disorder.
  • Fluency in Hebrew
  • Access to internet

Who cannot join

  • Substance use disorders
  • Past or present psychosis
  • High levels of suicidality
  • Changes in pharmacological treatment 3 months or less prior to the start of the trial
  • Participation in other psychotherapeutic treatments during the trial

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • University of Haifa

    Haifa

Other trials in Israel

About this study

Official title: Therapeutic Processes in Internet-Based CBT for Social Anxiety Disorder: A Randomized Controlled Trial.

The current study examines therapeutic processes during internet-based cognitive-behavioral therapy for social anxiety disorder. Participants will be randomized to either treatment or wait-list conditions. Participants in the wait-list condition will receive active treatment following the wait-list period.

Read the detailed description

Internet-based cognitive-behavioral therapy (iCBT) is an effective treatment for social anxiety disorder (SAD). However, little is known about the processes and mechanisms of change in this treatment. Compared to face to face (FTF) treatments, online interventions may operate through partially different mechanisms of change due to the text-based nature of the interaction and the reduced level of therapist involvement. The present randomized controlled trial will examine therapeutic processes during iCBT for SAD including the presence of sudden gains and their relationship to outcome, the relationship between anxiety and depressive symptoms along the course of treatment, changes in the therapeutic alliance and attrition from therapy. Moreover, we will compare iCBT for SAD with a wait-list control group and utilize weekly measurements of anxiety, depression, and SAD-related cognitions in both groups. This will facilitate comparison between temporal processes in both conditions and also shed light on processes occurring in wait-list conditions.

Being tested
Internet delivered CBT for social anxiety disorder
Keywords
Social anxiety disorder, iCBT, Therapeutic processes
Medical subject headings
Phobia, Social

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet delivered CBT for social anxiety disorderBehavioural

    An internet-based CBT for social anxiety based on a protocol from Andersson et al., 2006:

    "Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial."

Study groups in NCT03709615
Study groupRoleWhat they receive
Wait listNo interventionWait list condition with no active treatment, length of 10 weeks, with weekly measurements.
Intervention- active treatmentExperimentalInternet delivered CBT for social anxiety disorder
Receives: Behavioral: Internet delivered CBT for social anxiety disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Social anxiety severity

    Post treatment Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety

    Measured: Change from Baseline LSAS at post treatment (12 weeks)

  2. Diagnosis of SAD based on clinical interview

    Diagnoses derived from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS)

    Measured: Change from Baseline ADIS diagnosis at post treatment (12 weeks)

  3. Social anxiety severity

    Follow-up Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety

    Measured: Change from Baseline LSAS at 6 months follow-up

Secondary outcomes (2)
  1. Social anxiety severity - additional measure

    Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety

    Measured: Change from Baseline SPIN at post treatment (12 weeks)

  2. Social anxiety severity - additional measure

    Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety

    Measured: Change from Baseline SPIN at 6 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2018
  2. Study start20 Dec 2017
  3. Primary completion20 Jun 2020
  4. Study completion20 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03709615
Sponsor's protocol ID
UHaifaCBT
Status last verified
May 2021
First submitted
11 Dec 2017
Last updated
11 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Shalom JG, Strauss AY, Huppert JD, Andersson G, Aderka IM. A theoretically based experimental manipulation of the processing of sudden gains: Considering reasons, meaning, and opportunities to leverage the gain. J Consult Clin Psychol. 2025 Feb;93(2):120-130. doi: 10.1037/ccp0000941. Epub 2024 Dec 30.

    PubMed 39913487
  • Shalom JG, Strauss AY, Huppert JD, Andersson G, Agassi OD, Aderka IM. Predicting sudden gains before treatment begins: An examination of pretreatment intraindividual variability in symptoms. J Consult Clin Psychol. 2020 Sep;88(9):809-817. doi: 10.1037/ccp0000587. Epub 2020 Jun 25.

    PubMed 32584117

Questions about this trial

What is this clinical trial studying?

A study testing Internet delivered CBT for social anxiety disorder in people with Social Anxiety Disorder and Social Phobia, run by University of Haifa at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Social anxiety severity (time frame: Change from Baseline LSAS at post treatment (12 weeks)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03709615, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in